Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
API TR 408-1995: Toxicology of Petroleum Hydrocarbons – A Comprehensive Review
Understanding Health Risks and Safety Standards in the Petroleum Industry
Scope of API TR 408-1995
API TR 408-1995, officially titled “Toxicology of Petroleum Hydrocarbons: A Health Department Report,” is a technical document developed by the American Petroleum Institute (API) to consolidate toxicological data on key hydrocarbon compounds encountered in upstream and downstream petroleum operations. This report was prepared under the auspices of the API Health Department and serves as a reference for occupational health professionals, safety engineers, and industrial hygienists. The scope covers the systematic review of acute and chronic health effects, permissible exposure limits, and hazard classification for aliphatic, aromatic, and mixed petroleum hydrocarbons.
The document addresses substances such as benzene, toluene, ethylbenzene, xylene isomers, n-hexane, naphtha, and mineral spirits. It evaluates animal and human studies up to 1995 and provides critical dose-response relationships. The report explicitly does not cover combustion products or additives, focusing instead on pure hydrocarbons and typical refinery streams. It also excludes environmental fate and ecological toxicity, maintaining a strict human health focus. This scope was designed to align with OSHA, ACGIH, and NIOSH recommendations, and it informs workplace safety protocols across the petroleum supply chain.
Technical Requirements and Key Findings
API TR 408-1995 establishes a technical framework for evaluating hydrocarbon toxicity based on four criteria: route of exposure (inhalation, dermal, oral), target organ effects, carcinogenicity classification, and developmental/reproductive toxicity. The report uses a weight-of-evidence approach to rank hazards and recommends exposure control measures. Key findings include:
- Benzene is confirmed as a human carcinogen (Group 1 IARC) with leukemogenic effects at chronic low-level inhalation.
- n-Hexane causes peripheral neuropathy through its metabolite 2,5-hexanedione.
- Toluene exhibits neurotoxic and developmental effects, but no carcinogenic potential.
- Xylene isomers share similar inhalation thresholds and are associated with respiratory irritation and central nervous system depression.
- Mineral spirits and naphtha show low acute toxicity but can lead to aspiration pneumonia if ingested.
| Substance | ACGIH TLV-TWA (ppm) | OSHA PEL (ppm) | Key Health Effects |
|---|---|---|---|
| Benzene | 0.5 | 1 | Leukemia, bone marrow depression |
| Toluene | 20 | 200 | Neurotoxicity, fetal harm |
| m-Xylene | 100 | 100 | Respiratory irritation, CNS depression |
| n-Hexane | 50 | 500 | Peripheral neuropathy |
| Stoddard solvent | 100 | 500 | Dermal irritation, aspiration hazard |
Key point: The report emphasizes that combined exposures occur commonly in refineries, and the additive or synergistic effects should be assessed using mixture modeling rather than single-substance thresholds alone.
Implementation and Safety Protocols
API TR 408-1995 is not a specification standard but a guidance report. Its implementation involves integrating the toxicological benchmarks into an organization’s occupational health management system. Companies typically follow these steps:
- Exposure Assessment – Identify sources of hydrocarbon vapors and measure worker breathing-zone concentrations. The report provides recommended monitoring methods (charcoal tubes, gas chromatography).
- Hierarchy of Controls – Prioritize elimination, substitution, engineering controls (ventilation, enclosures), administrative controls (rotation, training), and personal protective equipment. The report supplies specific recommendations for each substance.
- Medical Surveillance – Establish baseline and periodic health assessments focusing on blood counts, liver function, and neurological examinations for at-risk personnel.
- Emergency Procedures – Define first aid measures and decontamination for acute spills or high exposures. The report includes dermal and inhalation first aid protocols.
Caution: The report notes that early warning signs of overexposure (e.g., headache, dizziness, skin irritation) are often subjective. Employers should not rely solely on symptom reporting; objective air monitoring is essential.
Best practice: Many operators use the API TR 408-1995 thresholds as default action limits in continuous monitoring systems, triggering alarms when TWA values approach 50% of the recommended levels.
Compliance and Regulatory Alignment
Compliance with API TR 408-1995 is voluntary, but its recommendations are frequently referenced by regulatory agencies. OSHA’s petroleum refinery process safety management standard (29 CFR 1910.119) does not explicitly incorporate TR 408, but industrial hygiene programs that follow the report’s exposure limits often satisfy the requirement for “recognized generally accepted good engineering practices.” Similarly, the report aligns with ACGIH TLVs and NIOSH RELs where applicable.
For international operations, API TR 408-1995 provides a basis for meeting European Commission Directive 2004/37/EC on carcinogens and mutagens at work, especially for benzene. In jurisdictions where national OELs are absent or outdated, companies can adopt the report’s values as interim standards. The report also notes that its findings may need re-evaluation as new epidemiological studies emerge; an update was anticipated but not formalized until later API publications (e.g., API TR 410-2013).
Legal note: Failure to address benzene exposures consistent with API TR 408 recommendations has been cited in litigation as evidence of inadequate hazard awareness. Maintaining documentation of adherence to this report can mitigate liability.
Frequently Asked Questions
Q: Who is the primary audience for API TR 408-1995?
A: The intended users are occupational health specialists, toxicologists, industrial hygienists, and safety managers in the petroleum and chemical industries. It is also a resource for regulatory bodies and workers’ compensation administrators.
A: The intended users are occupational health specialists, toxicologists, industrial hygienists, and safety managers in the petroleum and chemical industries. It is also a resource for regulatory bodies and workers’ compensation administrators.
Q: Is API TR 408-1995 still current?
A: While the report was published in 1995 and some exposure limits have since been updated by ACGIH and OSHA, the toxicological conclusions regarding mechanism and hazard identification remain broadly valid. Users should cross-check with newer API technical reports (e.g., API TR 410, 412) and national regulations.
Note: API withdrew TR 408 in 2010; it is no longer available for purchase, but archived copies are often retained by corporate libraries.
A: While the report was published in 1995 and some exposure limits have since been updated by ACGIH and OSHA, the toxicological conclusions regarding mechanism and hazard identification remain broadly valid. Users should cross-check with newer API technical reports (e.g., API TR 410, 412) and national regulations.
Note: API withdrew TR 408 in 2010; it is no longer available for purchase, but archived copies are often retained by corporate libraries.
Q: How does this report differ from API TR 410?
A: API TR 410 (formerly TR 410) focuses on the toxicology of petroleum hydrocarbon gases and vapors in confined spaces, whereas TR 408 addresses general occupational exposures in upstream and downstream settings with a stronger emphasis on mixture toxicology and medical surveillance.
A: API TR 410 (formerly TR 410) focuses on the toxicology of petroleum hydrocarbon gases and vapors in confined spaces, whereas TR 408 addresses general occupational exposures in upstream and downstream settings with a stronger emphasis on mixture toxicology and medical surveillance.
Q: What are the key limitations of API TR 408-1995?
A: The report does not cover nanoparticles, fuel additives, or long-term chronic effects such as immunotoxicity. It also does not include quantitative risk assessment per se, providing instead hazard identification and reference exposure levels. Users seeking comprehensive risk characterization may need additional sources.
A: The report does not cover nanoparticles, fuel additives, or long-term chronic effects such as immunotoxicity. It also does not include quantitative risk assessment per se, providing instead hazard identification and reference exposure levels. Users seeking comprehensive risk characterization may need additional sources.
This article is for informational purposes only and does not constitute legal advice or official endorsement. Always consult the latest regulatory requirements from your local authority. Document review based on API TR 408-1995. Last updated: 2026.